Royal Bank of Canada
RLYB icon

Royal Bank of Canada’s Rallybio RLYB Stock Holding History

Royal Bank of Canada’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-145
Closed -$2K – 7344
2024
Q2 		$2K Buy
145
+58
+67% +$786 ﹤0.01% 6748
2024
Q1 		$1K Sell
87
-1,053
-92% -$14.7K ﹤0.01% 6849
2023
Q4 		$22K Buy
1,140
+491
+76% +$12K ﹤0.01% 6276
2023
Q3 		$17K Buy
649
+105
+19% +$4.55K ﹤0.01% 6239
2023
Q2 		$25K Buy
544
+412
+312% +$20.2K ﹤0.01% 6101
2023
Q1 		$6K Sell
132
-220
-63% -$11.4K ﹤0.01% 6516
2022
Q4 		$18K Buy
352
+328
+1,367% +$19.4K ﹤0.01% 6347
2022
Q3 		$3K Buy
24
+13
+118% +$1.16K ﹤0.01% 6917
2022
Q2 		$1K Sell
11
-128
-92% -$9.62K ﹤0.01% 7190
2022
Q1 		$8K Sell
139
-60
-30% -$4.96K ﹤0.01% 7065
2021
Q4 		$15K Buy
199
+98
+97% +$11.4K ﹤0.01% 6919
2021
Q3 		$15K Buy
+101
New +$11.8K ﹤0.01% 6822

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada's RLYB Position: Q3 2024 in Review

Royal Bank of Canada sold out of Rallybio (RLYB) in Q3 2024, closing a stake of 145 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in RLYB in Q3 2021 and held it in 12 quarters. The position peaked at $25K in Q2 2023. 49 funds tracked by Wall St. Rank hold RLYB as of Q3 2024.

  • Royal Bank of Canada reported no remaining Rallybio position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 145 Rallybio shares in Q3 2024, an estimated $2K.
  • Royal Bank of Canada first reported a position in Rallybio in Q3 2021 and held it in 12 quarters.
  • Royal Bank of Canada's Rallybio position peaked at $25K in Q2 2023.
  • 49 funds tracked by Wall St. Rank held Rallybio as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.